Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
level disease » severe disease (Expand Search), vessel disease (Expand Search), lethal disease (Expand Search)
Showing 1,141 - 1,160 results of 39,386 for search '(( significant decrease decrease ) OR ( significant ((level disease) OR (greater decrease)) ))', query time: 0.57s Refine Results
  1. 1141
    Effects of allopurinol on cardiac myocyte apoptosis induced by chronic PG-LPS infusion.

    Effects of allopurinol on cardiac myocyte apoptosis induced by chronic PG-LPS infusion. by Akinaka Morii (12709672)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1142
    Schematic illustration of experimental procedure and comparison

    Schematic illustration of experimental procedure and comparison by Akinaka Morii (12709672)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1143
    Effects of allopurinol on PG-LPS-induced fibrosis in cardiac muscle.

    Effects of allopurinol on PG-LPS-induced fibrosis in cardiac muscle. by Akinaka Morii (12709672)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1144
    Effects of allopurinol on PG-LPS-induced phospho-CaMKII

    Effects of allopurinol on PG-LPS-induced phospho-CaMKII by Akinaka Morii (12709672)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1145
    Normality test using the Shapiro-Wilk test.

    Normality test using the Shapiro-Wilk test. by Akinaka Morii (12709672)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1146
    Tunel detection of myocardial apoptosis.

    Tunel detection of myocardial apoptosis. by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 1147
    Cardiomyocyte apoptosis rate in the CCM group.

    Cardiomyocyte apoptosis rate in the CCM group. by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 1148
    Cardiomyocyte apoptosis rate in the Sham group.

    Cardiomyocyte apoptosis rate in the Sham group. by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 1149
    Cardiomyocyte apoptosis rate in the three groups.

    Cardiomyocyte apoptosis rate in the three groups. by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 1150
    Apoptosis ratio in three groups.

    Apoptosis ratio in three groups. by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 1151
    S1 File -

    S1 File - by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1152
    Cardiomyocyte apoptosis rate in the HF group.

    Cardiomyocyte apoptosis rate in the HF group. by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 1153
    Predicted probability of infection symptoms due to forest cover for 2011 and 2016.

    Predicted probability of infection symptoms due to forest cover for 2011 and 2016. by Amit Timilsina (15203538)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1154
    Study variables.

    Study variables. by Amit Timilsina (15203538)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1155
    Descriptive statistics.

    Descriptive statistics. by Amit Timilsina (15203538)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1156
    Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr) or annually (1x/yr).

    Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1157
    Flow diagram of participant selection.

    Flow diagram of participant selection. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1158
    Bivariate association of characteristics of mothers (<34 weeks POG) who received and did not receive ACS.

    Bivariate association of characteristics of mothers (<34 weeks POG) who received and did not receive ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1159
    Supplementary file ACS.

    Supplementary file ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1160
    Multivariate analysis of the outcomes among the newborns who mothers receive or did not receive ACS.

    Multivariate analysis of the outcomes among the newborns who mothers receive or did not receive ACS. by Prajwal Paudel (7359209)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: